Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CE - US1508701034 - Common Stock

43.5 USD
+0.71 (+1.66%)
Last: 12/12/2025, 4:15:00 PM
43.5 USD
0 (0%)
After Hours: 12/12/2025, 4:15:00 PM
Fundamental Rating

3

CE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. Both the profitability and financial health of CE have multiple concerns. CE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CE had positive earnings in the past year.
CE had a positive operating cash flow in the past year.
Of the past 5 years CE 4 years were profitable.
In the past 5 years CE always reported a positive cash flow from operatings.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

CE has a worse Return On Assets (-13.95%) than 79.27% of its industry peers.
The Return On Equity of CE (-78.22%) is worse than 86.59% of its industry peers.
CE's Return On Invested Capital of 3.60% is in line compared to the rest of the industry. CE outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CE is in line with the industry average of 6.05%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.6%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CE has a Operating Margin (8.72%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CE has declined.
CE's Gross Margin of 21.33% is on the low side compared to the rest of the industry. CE is outperformed by 62.20% of its industry peers.
In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

CE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CE has more shares outstanding
CE has less shares outstanding than it did 5 years ago.
CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that CE is in the distress zone and has some risk of bankruptcy.
CE's Altman-Z score of 1.47 is on the low side compared to the rest of the industry. CE is outperformed by 70.73% of its industry peers.
CE has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as CE would need 12.55 years to pay back of all of its debts.
CE's Debt to FCF ratio of 12.55 is in line compared to the rest of the industry. CE outperforms 58.54% of its industry peers.
CE has a Debt/Equity ratio of 2.99. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.99, CE is doing worse than 85.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.47
ROIC/WACC0.5
WACC7.25%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CE has a Current Ratio of 1.63. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
CE has a worse Current ratio (1.63) than 64.63% of its industry peers.
A Quick Ratio of 1.04 indicates that CE should not have too much problems paying its short term obligations.
CE has a Quick ratio of 1.04. This is in the lower half of the industry: CE underperforms 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CE have decreased strongly by -47.48% in the last year.
CE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.59% yearly.
CE shows a decrease in Revenue. In the last year, the revenue decreased by -7.34%.
The Revenue has been growing by 10.30% on average over the past years. This is quite good.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

Based on estimates for the next years, CE will show a small growth in Earnings Per Share. The EPS will grow by 3.78% on average per year.
Based on estimates for the next years, CE will show a decrease in Revenue. The Revenue will decrease by -0.25% on average per year.
EPS Next Y-47.3%
EPS Next 2Y-16.65%
EPS Next 3Y-4.72%
EPS Next 5Y3.78%
Revenue Next Year-6.72%
Revenue Next 2Y-3.12%
Revenue Next 3Y-0.9%
Revenue Next 5Y-0.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.06 indicates a reasonable valuation of CE.
Compared to the rest of the industry, the Price/Earnings ratio of CE indicates a rather cheap valuation: CE is cheaper than 90.24% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CE to the average of the S&P500 Index (26.76), we can say CE is valued rather cheaply.
The Price/Forward Earnings ratio is 7.50, which indicates a rather cheap valuation of CE.
90.24% of the companies in the same industry are more expensive than CE, based on the Price/Forward Earnings ratio.
CE is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.06
Fwd PE 7.5
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CE is valued a bit cheaper than 62.20% of the companies in the same industry.
CE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CE is cheaper than 95.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.65
EV/EBITDA 9.83
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as CE's earnings are expected to decrease with -4.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.65%
EPS Next 3Y-4.72%

3

5. Dividend

5.1 Amount

CE has a yearly dividend return of 0.30%, which is pretty low.
Compared to an average industry Dividend Yield of 3.98, CE is paying slightly less dividend.
With a Dividend Yield of 0.30, CE pays less dividend than the S&P500 average, which is at 2.31.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CE decreased recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-2.78%
EPS Next 2Y-16.65%
EPS Next 3Y-4.72%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (12/12/2025, 4:15:00 PM)

After market: 43.5 0 (0%)

43.5

+0.71 (+1.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners103.6%
Inst Owner Change-3.23%
Ins Owners0.28%
Ins Owner Change0.94%
Market Cap4.76B
Revenue(TTM)9.71B
Net Income(TTM)-3.09B
Analysts73.6
Price Target54.09 (24.34%)
Short Float %7.31%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-2.78%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-28 2025-10-28 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)-3.31%
PT rev (3m)-3.27%
EPS NQ rev (1m)-6.71%
EPS NQ rev (3m)-15.47%
EPS NY rev (1m)0.28%
EPS NY rev (3m)-2.42%
Revenue NQ rev (1m)-3.73%
Revenue NQ rev (3m)-4.28%
Revenue NY rev (1m)-1.43%
Revenue NY rev (3m)-1.65%
Valuation
Industry RankSector Rank
PE 9.06
Fwd PE 7.5
P/S 0.49
P/FCF 4.65
P/OCF 3.43
P/B 1.2
P/tB N/A
EV/EBITDA 9.83
EPS(TTM)4.8
EY11.03%
EPS(NY)5.8
Fwd EY13.34%
FCF(TTM)9.35
FCFY21.5%
OCF(TTM)12.68
OCFY29.14%
SpS88.68
BVpS36.11
TBVpS-31.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number62.45
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.6%
ROICexc 3.9%
ROICexgc 6.84%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.47
F-Score4
WACC7.25%
ROIC/WACC0.5
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.3%
EPS Next 2Y-16.65%
EPS Next 3Y-4.72%
EPS Next 5Y3.78%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-6.72%
Revenue Next 2Y-3.12%
Revenue Next 3Y-0.9%
Revenue Next 5Y-0.25%
EBIT growth 1Y-23%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.66%
EBIT Next 3Y11.96%
EBIT Next 5Y9.04%
FCF growth 1Y-0.29%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-13.79%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


What is the valuation status for CE stock?

ChartMill assigns a valuation rating of 6 / 10 to CELANESE CORP (CE). This can be considered as Fairly Valued.


What is the profitability of CE stock?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 2 / 10.


What is the expected EPS growth for CELANESE CORP (CE) stock?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.3% in the next year.